Study presented at 2011 AAGL Global Congress shows benefits of
automated suturing device in benign cases of total laparoscopic
NORTH HAVEN, Conn., Nov 29, 2011 (BUSINESS WIRE) --
Covidien (NYSE: COV), a leading global provider of healthcare products,
today announced study data demonstrating that use of its Endo Stitch(TM)
automated suturing device lowers mean hospital costs and operating room
(OR) time during total laparoscopic hysterectomies treating benign
Using the Endo Stitch device in such procedures was associated with
lowering overall hospitalization costs by approximately $1,800 and
reducing OR time by approximately 40 minutes, on average, when compared
to those same procedures performed with robotic assistance.
The results, presented at the American Association of Gynecologic
Laparoscopists (AAGL) 40th Global Congress of Minimally
Invasive Gynecology, also revealed that mean operating room time in
cases where Covidien's Endo Stitch device was used in such procedures
was about 20 minutes less, when compared to procedures where neither a
robot nor an Endo Stitch device was utilized.
"In this tough economic environment, hospitals, payors and patients all
feel pressure to reduce costs and increase efficiency in the operating
room," said study co-presenter Stuart Hart, MD, FACOG, FACS,
Co-Director, University of South Florida Center for the Advancement of
Minimally Invasive Pelvic Surgery. "Minimally invasive procedures offer
the potential to reduce pain and trauma to the body, as well as to
enable quicker recovery resulting from smaller and fewer incisions.
Despite the proven benefits, however, the vast majority of
hysterectomies are still performed with open techniques."
Laparoscopic suturing is a vital skill for advanced laparoscopic
surgeons, but it is considered difficult to master when using
traditional manual techniques. Automated suturing devices, such as
Covidien's Endo Stitch, assist in the process and have been shown to
shorten the time needed to suture internal tissues through ports, when
compared to other techniques.
"New technologies like automated suturing devices and surgical robots
have made suturing inside the body easier, which may increase the number
of surgeons who adopt laparoscopic techniques," said co-presenter Craig
Sobolewski, MD, Chief, Division of Minimally Invasive Gynecologic
Surgery, Duke University Medical Center. "While robot-assisted suturing
has been shown to be clinically effective, this data indicates that
automated suturing with the Endo Stitch device during total laparoscopic
hysterectomy in benign cases can be associated with less expensive and
more efficient outcomes when the choice is between the two different
enabling intracorporeal suturing technologies."
According to the AAGL, fewer than 15% of the 600,000 hysterectomy
procedures performed annually in the United States are done
laparoscopically, largely due to lack of required training during a
surgeon's formal education program.1
"Covidien is committed to developing surgical instruments that enable
minimally invasive surgery, while helping to reduce overall costs to the
healthcare system." said Dean J Geraci, Director, Healthcare Economics
and Reimbursement, Covidien. "We are encouraged by these study results
and look forward to continued exploration of the clinical and economic
impact of enabling laparoscopic technologies."
About the Study
The study was a retrospective data analysis that compared the reported
overall hospital costs and OR time when utilizing the Endo Stitch
device, versus using robotic techniques, during total laparoscopic
hysterectomy in benign cases, as well as using neither the Endo Stitch
device nor robotic techniques in such cases.
The study analyzed inpatient hospitalization data from January 1, 2009,
to June 30, 2010, taken from Premier's Perspective(TM) Database (PPD).
Multivariate analysis using Generalized Estimating Equations was used
for the analysis, controlling for patient demographics and hospital
characteristics. The analysis included clustering of patients receiving
care from the same hospital.
A total of 5,731 patients were identified who underwent a total
laparoscopic hysterectomy (primary ICD-9-CM code 68.41) without a
primary diagnosis of cervical, uterine, ovarian or tubal cancers. Of
those procedures, 13% (n=727) utilized the Endo Stitch device, 50%
(n=2,853) used robotic assistance and 37% (n=2,151) used neither the
Endo Stitch device nor robotic assistance during the procedure.
Outcomes were adjusted for patient age, race, severity of illness,
co-morbidities, hospital bed-size, census region and teaching status,
and clustering by provider. The Endo Stitch device use compared to robot
use resulted in lower adjusted overall costs and less OR time: $7,820
vs. $9,689 (p=0.0096) and 173 minutes vs. 216 minutes (p = 0.0003),
Endo Stitch device use compared to neither devices used resulted in
lower OR time: 173 minutes vs. 194 minutes (p=0.0022), respectively. As
with other observational studies, some important factors may not have
been controlled for in the analysis, therefore no direct causation can
be definitively concluded.
Covidien is a leading global healthcare products company that creates
innovative medical solutions for better patient outcomes and delivers
value through clinical leadership and excellence. Covidien manufactures,
distributes and services a diverse range of industry-leading product
lines in three segments: Medical Devices, Pharmaceuticals and Medical
Supplies. With 2011 revenue of $11.6 billion, Covidien has 41,000
employees worldwide in more than 65 countries, and its products are sold
in over 140 countries. Please visit http://www.covidien.com
to learn more about our business.
1 Preliminary Program 40th AAGL Global Congress of Minimally
Invasive Gynecology. P. 11. Retrieved November 17, 2011 from the World
Wide Web: http://viewer.zmags.com/publication/80faeaf8#/80faeaf8/10.
Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50086344&lang=en
Marta Newhart, 303-476-7383
Communications & Public Affairs
Bruce Farmer, 508-452-4372
Coleman Lannum, CFA, 508-452-4343
Todd Carpenter, 508-452-4363